Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.48%
#2 Ocean Protocol Ocean Protocol +21.53%
#3 Geodnet Geodnet +15.00%
#4 Audiera Audiera +11.80%
#5 Cysic Cysic +8.78%
#6 KUB Coin KUB Coin +8.63%
#7 Arowana Arowana +7.85%
#8 DexNet DexNet +7.78%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +7.66%
#10 Rollbit Coin Rollbit Coin +6.27%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Medlab Clinical Limited Medlab Clinical Limited

Medlab Clinical Limited

MDC
Classificação em ações #32244
Medlab Clinical Limited is an Australian biotechnology firm dedicated to the... Medlab Clinical Limited is an Australian biotechnology firm dedicated to the research, development, and initial commercialization of innovative pharmaceutical and nutraceutical products. Its pipeline features key drug candidates such as NanaBis, a buccal spray derived from cannabis oil extract, intended for use in oncology and pain management. Another significant candidate is NanoCBD, a buccal spray sourced from hemp oil extract, aimed at supporting mental well-being. A core innovation is NanoCelle, a proprietary sub-micron drug delivery platform that enables the direct passive diffusion of active pharmaceutical ingredients into the bloodstream through diverse administration methods including oral-buccal, sublingual, intranasal, and transdermal or topical applications. The company also extends its offerings to include virtual clinic services. Founded in 2012, Medlab Clinical Limited is headquartered in Botany, Australia.
Preço da ação
$4.65
Última sincronização: 2024-07-24
Valor de mercado
$10.63M
Variação (1 dia)
6.66%
Variação (1 ano)
0.00%
País
AU
Negociar Medlab Clinical Limited (MDC)

Categoria

Healthcare
Histórico de preços das ações de Medlab Clinical Limited (MDC)
Preço de fecho mais alto: $4.65 em 2024-07-01

Preço de fecho mais baixo: $20.06 em 2015-07-01
Histórico de preços das ações da Medlab Clinical Limited de 2015 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2024 5.52%
2023 -8.38%
2022 -69.42%
2021 -45.35%
2020 -15.13%
2019 -18.05%
2018 -52.21%
2017 -8.72%
2016 360.38%
2015 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.17 -36.90%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.06K -6.61%
KR